# A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines

> **NCT02032160** · NA · COMPLETED · sponsor: **University of Surrey** · enrollment: 30 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Engerix B IM injection - 20ug
- **BIOLOGICAL:** Fendrix IM injection - 20ug

## Key facts

- **NCT ID:** NCT02032160
- **Lead sponsor:** University of Surrey
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02032160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02032160, "A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02032160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*